Figure 2
Figure 2. Recovering lymphocytes are mostly CD3+CD4+, and there is a much larger than expected population of CD3+CD4+CD25+Foxp3+ T cells. Flow cytometric analysis of peripheral blood lymphocytes isolated from patients during the early phase of lymphocyte recovery after induction chemotherapy showed that there is significant recovery of CD3+CD4+ and CD3+CD8+ cells. Data from 1 representative patient are shown on the left. CD3+ cells constituted a median of 73.4% (range, 19%-93%) of the recovering mononuclear cells. Of CD3+ cells, CD8+ cells constituted a median of 16.7%, whereas CD4+ cells constituted a median of 66.4%. Surprisingly, there also was a rapid and significant recovery of regulatory T cells (median, 10.5% of CD4+ T cells), which were phenotypically identified by the coexpression of CD3, CD4, CD25, and Foxp3.

Recovering lymphocytes are mostly CD3+CD4+, and there is a much larger than expected population of CD3+CD4+CD25+Foxp3+ T cells. Flow cytometric analysis of peripheral blood lymphocytes isolated from patients during the early phase of lymphocyte recovery after induction chemotherapy showed that there is significant recovery of CD3+CD4+ and CD3+CD8+ cells. Data from 1 representative patient are shown on the left. CD3+ cells constituted a median of 73.4% (range, 19%-93%) of the recovering mononuclear cells. Of CD3+ cells, CD8+ cells constituted a median of 16.7%, whereas CD4+ cells constituted a median of 66.4%. Surprisingly, there also was a rapid and significant recovery of regulatory T cells (median, 10.5% of CD4+ T cells), which were phenotypically identified by the coexpression of CD3, CD4, CD25, and Foxp3.

Close Modal

or Create an Account

Close Modal
Close Modal